Dual Status Rx/OTC Plan B In The Works? Barr Weighs Its Options
This article was originally published in The Tan Sheet
Executive Summary
Barr hinted that it is leaning toward a dual label Rx/OTC approach in seeking FDA approval to switch the Plan B "morning after" pill